New

Keep tabs on your favorite ETFs with a personalized weekly tracker. Create a Watchlist now →

Advertisement
ETF Central logo
Advertisement

BMEDvsFTXHETF Comparison

ETF 1
BMED

iShares Health Innovation Active ETF

This fund is part of
Healthcare Technology
-0.41%
Full BMED fund page
VS
ETF 2
FTXH

First Trust Nasdaq Pharmaceuticals ETF

This fund is part of
US Health Care
-2%
Full FTXH fund page

iShares Health Innovation Active ETF (BMED) belongs to the Healthcare Technology segment. First Trust Nasdaq Pharmaceuticals ETF (FTXH) is part of the US Health Care segment. BMED's top 3 sector exposures are Health Care and Consumer Discretionary. In contrast, FTXH's top sector exposures are Health Care  BMED is more expensive with a Total Expense Ratio (TER) of 0.77%, versus 0.6% for FTXH. BMED is down -4.83% year-to-date (YTD) with +$4M in YTD flows. FTXH performs better with 2.6% YTD performance, and +$7M in YTD flows. Run a side-by-side ETF comparison of BMED and FTXH below, and assess how they stack up in performance, liquidity, risk, exposure, holdings, and more, helping you select the best ETF for your investments.

Find out how industry players manage ETF portfolios.  Discover our library of Model portfolios

BMED vs FTXH performance and flow charts

Performance

-4.0-2.00.02.0%Feb 12Feb 20Feb 27Mar 6

Cumulative Flows

0 M1 M2 M3 M4 MFeb 12Feb 20Feb 27Mar 6

Get all the metrics on this page, and more, through a reliable ETF data feed

Daily, global ETF data for advanced analysis or integration into apps (API), from our partner Trackinsight.

Historic performance and flows
Data as of 03/12/2026
1M3MYTD1Y3Y5Y
Perf.
BMED
FTXH
-4.90%-2.89%
-4.61%+3.86%
-4.83%+2.60%
+16.18%+22.74%
+28.25%+39.72%
-0.73%+37.82%
Flows
BMED
FTXH
+$1M+$4M
+$4M+$9M
+$4M+$7M
+$7M+$10M
+$4M-$13M
+$5M+$7M
Volatility and drawdown
3M1Y3Y5Y
Volatility
BMED
FTXH
+15.24%+15.86%
+17.95%+20.64%
+15.51%+15.91%
+17.58%+15.69%
Max drawdown
BMED
FTXH
-9.78%-5.21%
-14.01%-16.42%
-19.76%-19.32%
-33.96%-19.32%
Max drawdown duration
BMED
FTXH
49d11d
113d165d
237d393d
1586d393d
Trading data

Create an account to view trading data

Join for free
BMED
FTXH
Last sale
3/13/2026 at 1:30 PM
$28.63
$33.63
Previous close
03/12/2026
$28.78
$33.78
Consolidated volume
03/12/2026
Average volume
30 days
Average discount or premium
30 days
Average Bid/Ask spread
30 days
Replication quality
Data as of February 27, 2026
1-year trailing difference

Create an account to view replication metrics

Join for free

BMED
is actively managed and doesn’t replicate an index

Create an account to view replication quality

Join for free
BMED
FTXH
Tracking error
Tracking difference
1 year cumulative return difference
Best
Worst
Daily return difference
Average
Worst
Advertisement
Main metrics
Last update 3/13/2026 at 1:30 PM
Live
Closed
BMED
FTXH
Last price
$28.63
$33.63
1D performance
-0.52%
-0.46%
AuM$10.38 M$28.72 M
E/R0.77%0.6%
Characteristics
BMED
FTXH
Management strategyActivePassive
ProvideriSharesFirst Trust
Benchmark-NASDAQ US Smart Pharmaceuticals Index
N° of holdings11049
Asset class-Equities
Trailing 12m distribution yield
Join
Join
Inception dateSeptember 29, 2020September 20, 2016
ESGNoNo
Advertisement
Exposure

Countries

BMED
USA
79.87%
Other
20.13%
FTXH
USA
95.63%
Other
4.37%

Sectors

BMED
Health Care
87.16%
Other
12.84%
FTXH
Health Care
98.8%
Other
1.2%
Advertisement

Diversification

BMED

Total weight of top 15 holdings out of 15

38.18%
FTXH

Total weight of top 15 holdings out of 15

71.63%

Top 15 holdings

Data as of January 31, 2026
BMED
JOHNSON&JOHNSON
3.55%
GILEAD SCIENCES
3.01%
EXACT SCIENCES
2.93%
MEDTRONIC PLC
2.85%
US0669224778
2.70%
GUARDANT HEALTH INC
2.65%
MERCK & CO INC
2.60%
ROCHE
2.60%
EDWARDS LIFESCIENCES
2.45%
MODERNA INC
2.34%
IQVIA HOLDINGS INC
2.26%
NOVARTIS
2.11%
NATERA
2.08%
BIOGEN INC
2.05%
GENMAB
2.00%
FTXH
MERCK & CO INC
7.83%
JOHNSON&JOHNSON
7.66%
BRISTOL-MYERS SQUIBB
6.97%
PFIZER
6.38%
ABBVIE
6.33%
CARDINAL HEALTH
4.31%
LILLY
4.23%
BIOGEN INC
3.99%
REGENERON PHARMACEUTICALS
3.81%
GILEAD SCIENCES
3.75%
VIATRIS INC
3.71%
VERTEX PHARMACEUTICALS
3.59%
AMGEN-T
3.55%
UTD THERAPEUT
3.14%
ZOETIS INC
2.38%
Frequently asked questions about BMED and FTXH

How have the BMED and FTXH ETFs performed in 2026?

As of March 12, 2026, BMED is down -4.83% year-to-date (YTD), while FTXH has returned 2.6%. That puts FTXH better performer ahead so far this year.

Which ETF is attracting more investor money: BMED or FTXH?

Year-to-date, the BMED ETF saw +$4M in flows, compared to +$7M for FTXH.

Which ETF is more volatile: BMED or FTXH?

Over the past year, BMED had a volatility of 17.95%, while FTXH experienced 20.64%.

Which ETF is bigger: BMED or FTXH?

As of March 12, 2026, BMED holds $10.38 M in assets under management (AUM), while FTXH manages $28.72 M.

What sectors do the BMED and FTXH ETFs invest in?

BMED leans toward sectors like Health Care. Meanwhile, FTXH focuses on Health Care.

What are the top holdings of the BMED ETF and FTXH ETF?

BMED top holdings include JOHNSON&JOHNSON, GILEAD SCIENCES and EXACT SCIENCES. FTXH holds in its top three: MERCK & CO INC, JOHNSON&JOHNSON and BRISTOL-MYERS SQUIBB.

Which ETF is more diversified: BMED or FTXH?

BMED holds 144 securities with 38.18% of its assets in the top 15. FTXH has 50 securities and a top 15 weight of 71.63%.

Advertisement
Advertisement
Advertisement
The Active Trader Report

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up

Direxion partnered with Compound Insights and Vanda to explore what’s driving the evolution of active trading — and how active traders are using leveraged and inverse funds across equities, single stocks, commodities, and volatility.

Active Trader Report: Use of Leveraged & Inverse ETFs Way Up